ORIGINAL PAPER
RSV versus non-RSV bronchiolitis in infants and young children – the bedside characteristics of one epidemic season
More details
Hide details
Submission date: 2018-12-10
Final revision date: 2019-01-12
Acceptance date: 2019-01-18
Publication date: 2019-02-27
Pediatr Pol 2019;94(1):18-24
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Acute lower respiratory infection (ALRI), comprising both bronchiolitis and pneumonia, is a global leading cause of morbidity and hospital admissions of infants and young children, with respiratory syncytial virus (RSV) being a major viral cause. Guidelines recommend a clinical diagnosis of bronchiolitis but do not advise how to distinguish between different viral aetiologies using clinical, laboratory, and radiological criteria.
Aim of the study:
The aim of this study was to provide clinical data that characterise RSV and non-RSV aetiology of bronchiolitis for the purpose of better defining the correlations between the viral aetiology and clinical characteristics as well as the risk factors of severe disease.
Material and methods:
We retrospectively reviewed 135 records of 116 infants and young children who were hospitalised due to bronchiolitis during one infectious season. A detailed analysis of patients’ medical history, clinical course of bronchiolitis, viral aetiology of infection, basic laboratory tests, as well as radiological findings was performed.
Results:
Children with RSV bronchiolitis more frequently demonstrated obstruction of the lower airways manifesting with diminished breath sounds and crackles on auscultation and more severe course of the disease than non-RSV patients, defined as hypoxaemia and desaturation, the need for supplemental oxygen, longer duration of oxygen therapy, and a longer hospitalisation.
Conclusions:
Clinical symptoms of obstruction of lower airways are more frequent and more severe in RSV than in non-RSV bronchiolitis. Because basic laboratory tests and chest radiographs are not helpful in distinguishing between RSV and non-RSV bronchiolitis, their use in uncomplicated cases should be limited. Therefore, careful clinical assessment and monitoring of children with bronchiolitis is of utmost importance in predicting the course of ALRI and in the implication of therapeutic decisions.
REFERENCES (30)
1.
Miller KE, Gebretsadik T, Carroll KN, et al. Viral etiologies of infant bronchiolitis, croup, and upper respiratory illness during four consecutive years. Pediatr Infect Dis J 2013: 32: 950-955.
2.
Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev 2014; 35: 519-530.
3.
Cangiano G, Nenna R, Frassanito A, et al. Bronchiolitis: analysis of 10 consecutive epidemic seasons. Pediatr Pulmonol 2016; 51: 1330-1335.
4.
Raiston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2016; 134: e1474-e1502.
5.
Ramagopal G, Brow E, Mannu A, et al. Demographic, clinical and hematological profile of children with bronchiolitis: a comparative study between respiratory syncytial virus (RSV) and non (RSV) groups. J Clin Diagn Res 2016; 10: SC05-SC08.
6.
Garcia CG, Bhore R, Soriano-Fallas A, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 2010; 126: e1453-1460.
7.
Breese Hall C, Weinberg GA, Blumkin AK, et al. Respiratory-syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics 2013; 132: e341-348.
8.
Marguet C, Lubrano M, Gueudin M, et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS One 2009; 4: e4596.
9.
Munywoki PK, Koech DC, Agoti CN, et al. Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding. Epidemiol Infect 2015; 143: 804-812.
10.
Hervas D, Reina J, Yanez A, et al. Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis. Eur J Clin Microbiol Infect Dis 2012; 31: 1975-1981.
11.
Berg AS, Inchley CS, Fjaerli HO, et al. Clinical features and inflammatory markers in a pediatric pneumonia: a prospective study. Eur J Pediatr 2017; 176: 629-638.
12.
Bont L, Checchia PA, Fauroux B, et al. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in western countries. Infect Dis Ther 2016; 5: 271-298.
13.
El Hajje MJ, Lambe C, Moulin F, et al. The burden of respiratory viral disease in hospitalized children in Paris. Eur J Pediatr 2008; 167: 435-436.
14.
Moesker FM, van Kampen JJ, Aron G, et al. Diagnostic performance of influenza viruses and RSV rapid antigen detection tests in children in tertiary care. J Clin Virol 2016; 79: 12-17.
15.
Chartrand C, Tremblay N, Renaud C, et al. Diagnostic accuracy of rapid detection tests for respiratory syncytial virus infection: systematic review and meta-analysis. J Clin Microbiol 2015; 53: 3738-3749.
16.
Nagayama Y, Tsubaki T, Nakayama S, et al. Gender analysis in acute bronchiolitis due to respiratory syncytial virus. Pediatr Allergy Immunol 2006; 17: 29-36.
17.
Hacimustafaoglu M, Celebi S, Bozdemir SE, et al. RSV frequency in children below two years hospitalized for lower respiratory tract infection. Turk J Pediatr 2016; 55: 130-139.
18.
Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Resp Rev 2004; 5 (Suppl A): s119-126.
19.
Smith DK, Seales S, Budzik C. Respiratory syncytial virus bronchiolitis in children. Am Fam Physician 2017; 95: 94-98.
20.
Abraha HY, Lanctot KL, Paes B. Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention. Expert Rev Respir Med 2015; 9: 779-799.
21.
Simoes EA, Anderson EJ, Wu X, et al. Effects of chronologic age and young children exposure on respiratory syncytial virus disease among US preterm infants born at 32 to 35 weeks gestation. PLoS One 2016; 11: e0166226.
22.
Anderson EJ, Carbonell-Estrany X, Blanken M, et al. Burden of severe respiratory virus disease among 33-35 weeks gestational age infants born during multiple respiratory syncytial virus seasons. Pediatr Infect Dis 2017; 36: 160-167.
23.
Zuccotti G, Fabiano V. Indications to respiratory syncytial virus immunoprophylaxis in the 29-32 wGA group: is there still room for debating? Ital J Pediatr 2017; 43: 17.
24.
Bollani L, Baraldi E, Chirico G, et al. Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV). Ital J Pediatr 2015; 41: 97.
25.
Manoha C, Espinosa S, Aho SL, et al. Epidemiological and clinical features of hMPV, RSV and RVs infections in young children. J Clin Virol 2007; 38: 221-226.
26.
Bamberger E, Srugo I, Abu Raya B, et al. What is the clinical relevance of respiratory syncytial virus bronchiolitis?: findings from a multi-center, prospective study. Eur J Clin Microbiol Infect Dis 2012; 31: 3323-3330.
27.
Justicia-Grande AJ, Pardo-Seco J, Cebey-Lopez M, et al. Development and validation of a new clinical scale for infants with acute respiratory infection: the ReSVinet Scale. PloS One 2016; 11: e0157665.
28.
Dumas O, Mansbach JM, Jartti T, et al. A clustering approach to identify severe bronchiolitis profiles in children. Thorax 2016; 71: 712-718.
29.
Friedman JN, Rieder MJ, Walton JM. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health 2014; 19: 485-491.
30.
Arnoux V, Carsin A, Bosdure E, et al. Chest X-ray and acute bronchiolitis: are these indications decreasing? Arch Pediatr 2017; 24: 10-16.